MASSACHUSETTS
-
New research suggests that ethnic East Asians--but not ethnic South Asians--underperform in US business and law schools due to a cultural mismatch in assertiveness
A surprising "bamboo ceiling" in the classroom CAMBRIDGE, Mass., April 12, 2022 /PRNewswire/ -- In the US, Asians are often viewed as the "model minority" as a result of their outstanding academic ach…
-
Persephone Biosciences and Ginkgo Bioworks Announce Collaboration to Develop Novel Therapeutics
Multi-project agreement involves engineering of anaerobic species, a critical component for microbiome medicines SAN DIEGO and BOSTON, April 12, 2022 /PRNewswire/ --
-
Vedere Bio II Announces Appointment of Industry Veteran Gina Consylman as Chief Financial Officer
CAMBRIDGE, Mass., April 12, 2022 /PRNewswire/ -- Vedere Bio II, Inc., a company developing transformative, next-generation therapies for vision restoration and preservation, today announced the appoin…
-
HERITAGE FINANCIAL PLACES #2 ON FORBES' BEST-IN-STATE WEALTH ADVISORS LIST
WESTWOOD, Mass., April 12, 2022 /PRNewswire/ -- Heritage Financial Services, an independent wealth management firm with offices in Westwood and Woburn, MA, is proud to announce that its Founder and CE…
-
Proven Behavior Solutions Announces Strategic Investment by Health Enterprise Partners
Leading Applied Behavior Analysis Provider to Expand Geographic Reach and Services
-
American Student Assistance Hosts Free, Virtual Event Series to Help Middle and High Schoolers Learn About Careers Beyond the Classroom
BOSTON, April 11, 2022 /PRNewswire/ -- American Student Assistance® (ASA), a national nonprofit changing the way middle and high schoolers learn about careers and navigate education-to-career opportun…
-
Goulston & Storrs Adds Two Laterals as Counsel in its Real Estate Group
Amelie H. Mailloux joins the firm's Boston office and Ronald G. Nelson joins in New York City BOSTON and NEW YORK, April 11, 2022 /PRNewswire/ --
-
Liberty All-Star® Equity Fund Declares Distribution
BOSTON, April 11, 2022 /PRNewswire/ -- The Board of Trustees of Liberty All-Star Equity Fund (NYSE: USA) has declared a distribution of $0.18 per share payable on June 6, 2022 to shareholders of recor…
-
Liberty All-Star® Growth Fund, Inc. Declares Distribution
BOSTON, April 11, 2022 /PRNewswire/ -- The Board of Directors of Liberty All-Star Growth Fund, Inc. (NYSE: ASG) has declared a distribution of $0.14 per share payable on June 6, 2022 to shareholders o…
-
Jobcase Strengthens Engineering Leadership while Further Investing in Workforce Data Expertise
CTO, Paw Andersen joins team as Tony Deigh moves into Chief Data Officer role CAMBRIDGE, Mass., April 11, 2022 /PRNewswire/ -- Jobcase, an online community dedicated to empowering and advocating for w…
-
Rockwell Medical Expands Partnership with DaVita
$7.5M initial equity investment in Rockwell Amended and expanded supply agreement Strengthens Rockwell's financial position, laying groundwork for improved concentrate business WIXOM, Mich., April 11,…
-
LLumin Accepted into Mitsubishi Electric e-F@ctory Alliance Partner Program
SPRINGFIELD, Mass., April 11, 2022 /PRNewswire/ -- LLumin, a premier CMMS (computerized maintenance management system) provider, announces its participation in the e-F@ctory Alliance Partner Program b…
-
NeuroSense Therapeutics Commences Enrollment and Dosing in its Pharmacokinetic Study of PrimeC for ALS
Study conducted under FDA cleared protocol in parallel with international Phase IIb trial expected to commence in Q2 2022 CAMBRIDGE, Mass., April 11, 2022 /PRNewswire/ -- NeuroSense Therapeutics Ltd.…
-
Biostage Further Strengthens IP Portfolio with Additional Patent for Regeneration and Repair of the Bronchus
Extends Core Intellectual Property coverage for treatment of lung cancer as well as esophageal cancer. HOLLISTON, Mass., April 11, 2022 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the…
-
Stealth BioTherapeutics Announces $8.5 Million in Equity Financings
BOSTON, April 11, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO) (the "Company"), a clinical-stage biotechnology company focused on the discovery, development and commercialization o…
-
Obsidian Therapeutics to Present Preclinical Data from cytoTIL15™ Program at the American Associate of Cancer Research (AACR) Annual Meeting 2022
Data demonstrate significantly greater anti-tumor activity of cytoTIL15 therapy in vivo compared to conventional TIL + IL2 therapy CAMBRIDGE, Mass., April 11, 2022 /PRNewswire/ -- Obsidian Therapeutic…
-
FORM Named A Top 10 Audit Management Company of 2022 For Mobile Inspection Software
Insights Success Evaluated Global Software Providers Improving Compliance Outcomes for Environment, Health, Safety, and Operational Business Processes QUINCY, Mass., April 11, 2022 /PRNewswire/ -- FOR…
-
Babson College Announces Naming of the Bertarelli Institute for Family Entrepreneurship
Institute Creates Global Family Entrepreneurship Network Empowering Enterprising Families to Create Economic Value and Social Impact Built Upon Foundation of Stronger Family Relationships WELLESLEY, M…
-
Tive Raises $54M in Series B Funding Led by AXA Venture Partners
300%+ revenue growth, 200+ new global customers, and hired 100+ employees in 2021, six new investors in the B round, and thousands of shipments saved from delays, spoilage, damage or loss. BOSTON, Apr…
-
Curis Announces FDA Partial Clinical Hold for TakeAim Lymphoma Study of Emavusertib (CA-4948)
Curis voluntarily paused enrollment in this study earlier LEXINGTON, Mass., April 11, 2022 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative…